| Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate VX Fu, JR Dobosy, JA Desotelle, N Almassi, JA Ewald, R Srinivasan, ... Cancer research 68 (16), 6797-6802, 2008 | 103 | 2008 |
| A methyl‐deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate JR Dobosy, VX Fu, JA Desotelle, R Srinivasan, ML Kenowski, N Almassi, ... The Prostate 68 (11), 1187-1195, 2008 | 87 | 2008 |
| Benign prostatic hyperplasia: evaluation and medical management in primary care MD RAMAN UNNIKRISHNAN, N Almassi, K Fareed Cleveland Clinic journal of medicine 84 (1), 53, 2017 | 66 | 2017 |
| Association of HSD3B1 genotype with response to androgen-deprivation therapy for biochemical recurrence after radiotherapy for localized prostate cancer JWD Hearn, W Xie, M Nakabayashi, N Almassi, CA Reichard, ... JAMA oncology 4 (4), 558-562, 2018 | 63 | 2018 |
| HSD3B1 genotype and clinical outcomes in metastatic castration-sensitive prostate cancer JWD Hearn, CJ Sweeney, N Almassi, CA Reichard, CA Reddy, H Li, ... JAMA oncology 6 (4), e196496-e196496, 2020 | 57 | 2020 |
| Superoxide dismutase 1 knockdown induces oxidative stress and DNA methylation loss in the prostate SS Bhusari, JR Dobosy, V Fu, N Almassi, T Oberley, DF Jarrard Epigenetics 5 (5), 402-409, 2010 | 57 | 2010 |
| HSD3B1 and response to a nonsteroidal CYP17A1 inhibitor in castration-resistant prostate cancer N Almassi, C Reichard, J Li, C Russell, J Perry, CJ Ryan, T Friedlander, ... JAMA oncology 4 (4), 554-557, 2018 | 55 | 2018 |
| Drug-induced senescence bystander proliferation in prostate cancer cells in vitro and in vivo JA Ewald, JA Desotelle, N Almassi, DF Jarrard British journal of cancer 98 (7), 1244-1249, 2008 | 55 | 2008 |
| HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer M Alyamani, H Emamekhoo, S Park, J Taylor, N Almassi, S Upadhyay, ... The Journal of clinical investigation 128 (8), 3333-3340, 2018 | 49 | 2018 |
| Change in psoas muscle volume as a predictor of outcomes in patients treated with chemotherapy and radical cystectomy for muscle-invasive bladder cancer H Zargar, N Almassi, E Kovac, C Ercole, E Remer, B Rini, A Stephenson, ... Bladder Cancer 3 (1), 57-63, 2017 | 49 | 2017 |
| Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts K Kim, W Hu, F Audenet, N Almassi, AJ Hanrahan, K Murray, A Bagrodia, ... Nature communications 11 (1), 1975, 2020 | 44 | 2020 |
| Intermediate-term outcomes for men with very low/low and intermediate/high risk prostate cancer managed by active surveillance YA Nyame, N Almassi, SC Haywood, DJ Greene, V Ganesan, C Dai, ... The Journal of Urology 198 (3), 591-599, 2017 | 42 | 2017 |
| Impact of neoadjuvant chemotherapy on pathologic response in patients with upper tract urothelial carcinoma undergoing extirpative surgery N Almassi, T Gao, B Lee, RJ Stein, GP Haber, MC Ornstein, BI Rini, ... Clinical Genitourinary Cancer 16 (6), e1237-e1242, 2018 | 38 | 2018 |
| Management of the small renal mass N Almassi, BC Gill, B Rini, K Fareed Translational Andrology and Urology 6 (5), 923, 2017 | 38 | 2017 |
| Ileal conduit or orthotopic neobladder: selection and contemporary patterns of use N Almassi, BH Bochner Current opinion in urology 30 (3), 415-420, 2020 | 31 | 2020 |
| Feasibility of cisplatin-based neoadjuvant chemotherapy in muscle-invasive bladder cancer patients with diminished renal function VS Koshkin, PC Barata, LA Rybicki, H Zahoor, N Almassi, AM Redden, ... Clinical genitourinary cancer 16 (4), e879-e892, 2018 | 31 | 2018 |
| Integrity of prostatic tissue for molecular analysis after robotic-assisted laparoscopic and open prostatectomy S Best, Y Sawers, VX Fu, N Almassi, W Huang, DF Jarrard Urology 70 (2), 328-332, 2007 | 28 | 2007 |
| American Urological Association antibiotic best practice statement and ureteroscopy: does antibiotic stewardship help? DJ Greene, BC Gill, B Hinck, YA Nyame, N Almassi, V Krishnamurthi, ... Journal of Endourology 32 (4), 283-288, 2018 | 25 | 2018 |
| Management of challenging urethro-ileal anastomosis during robotic assisted radical cystectomy with intracorporeal neobladder formation N Almassi, H Zargar, V Ganesan, A Fergany, GP Haber European Urology 69 (4), 704-709, 2016 | 25 | 2016 |
| Comparative cost-effectiveness analysis of modified 1-layer versus formal 2-layer vasovasostomy technique YA Nyame, P Babbar, N Almassi, AS Polackwich, E Sabanegh The Journal of Urology 195 (2), 434-438, 2016 | 23 | 2016 |
Andrew StephensonAssociate Professor of Surgery, Cleveland ClinicVerified email at ccf.org
